- Fraudulent Email Warning(27KB)
News Release
- April 10, 2024
- Nipro Pharma Odate Plant Receives U.S. Food and Drug Administration (FDA) Certification as a Manufacturing Site (42KB)
- April 5, 2024
- Instruction for New Employees from President Sano at Induction Ceremony on April 1, 2024 (162KB)
- January 16, 2024
- Notice of Participation in OSAKA Healthcare Pavilion at Expo 2025 Osaka, Kansai, Japan (159KB)
IR News
- February 21, 2024
- IR Materials
- November 29, 2023
- IR Materials
- September 28, 2023
- Annual Report
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.